| Tracy L. Bale Ph.D. |
| Assistant Professor of Neuroscience Department of Animal Biology 3800 Spruce Street School of Veterinary Medicine University of Pennsylvania Philadelphia , PA 19104-6010 |
| Qualifications |
|
1997 Ph.D. pharmacology/neurobiology, University of Washington, Seattle, WA 1992 BS molecular biology/genetics, Washington State University |
| Memberships |
| Society for Neuroscience Society for Behavioral Neuroendocrinology Endocrine Society |
| Clinical Interests |
|
Obesity |
| Research Interests |
| The main interest of this laboratory is deciphering the role stress plays in disrupting homeostasis. The specific areas we are interested in include the effect stress has on the development of depression, anxiety, and obesity and metabolic disorders. We are interested in how neuropeptides produced in the hypothalamus regulate stress responsivity. A key factor modulating stress responses is the neuropeptide corticotropin-releasing factor (CRF). CRF and its family of ligands and receptors (CRFR1 and CRFR2) regulate the hypothalamic-pituitary-adrenal stress axis by coordinating functions such that homeostasis is maintained. Dysregulation of this axis can lead to the development of stress-related mood disorders including anxiety and depression. We are interested in understanding the genetics behind heightened stress sensitivity and in determining the effects this has on gestational development as well as on long-term physiological, behavioral, and emotional health. In these efforts, we utilize a genetically modified mouse model of elevated stress sensitivity and responsivity. From our studies, we hope to begin to decipher the genes and molecular mechanisms underlying risk factors and thereby direct our resources toward more identifiable prevention and treatment for stress-related disorders.
Current areas of research interest:
|
| Selected Publications |
| Bale TL and Vale WW (2003) Increased depression-like behaviors in corticotropin-releasing factor receptor-2 deficient mice: sexually dichotomous responses. Journal of Neuroscience, 23:5295-5301
Bale TL, Anderson KR, Roberts A, Lee K-F, Nagy T, and Vale WW (2003) Corticotropin-releasing factor receptor-2 deficient mice display abnormal homeostatic responses to challenges of increased dietary fat and cold. Endocrinology, 144:2580-2587 Bale TL, Giordano FJ, and Vale WW (2003) A new role for corticotropin-releasing factor receptor-2: suppression of vascularization. Trends in Cardiovascular Medicine, 13:68-72 Bale TL, Giordano FJ, Hickey RP, Huang Y, Nath AK, Peterson KL, Lee K-F, and Vale WW (2002) Corticotropin-releasing factor receptor-2 is a tonic suppressor of vascularization. Proceedings of the National Academy of Sciences USA, 99:7734-7739 Bale TL, Picetti R, Contarino A, Koob GF, Vale WW, and Lee K-F (2002) Mice deficient for both CRFR1 and CRFR2 have an impaired stress response and display sexually dichotomous anxiolytic-like behavior. Journal of Neuroscience, 22:193-199 Bale TL, Davis AM, Auger AP, Dorsa DM, and McCarthy MM (2001) CNS region specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. Journal of Neuroscience, 21:2546-2552 Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, and Lee K-F (2000) Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behavior and are hypersensitive to stress. Nature Genetics, 24:410-414 |